Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia
Clinical trial NCT04581785 · TERMINATED
Trial details
- NCT number
- NCT04581785
- Sponsor
- LogicBio Therapeutics, Inc
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-29
- Primary completion
- 2023-01-10
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.